Cardiovascular Systems Profit Margin 2006-2019 | CSII

Current and historical gross margin, operating margin and net profit margin for Cardiovascular Systems (CSII) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cardiovascular Systems net profit margin as of June 30, 2019 is -0.1%.
Cardiovascular Systems Annual Profit Margins
Cardiovascular Systems Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.586B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.122B 20.23
Abbott Laboratories (ABT) United States $141.639B 26.63
Stryker (SYK) United States $79.044B 27.33
Boston Scientific (BSX) United States $52.905B 25.66
Baxter (BAX) United States $44.730B 27.12
EssilorLuxottica Societe Anonyme (ESLOY) France $31.899B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.527B 17.62
Coloplast (CLPBY) Denmark $24.516B 39.14
Lonza Group Ag (LZAGY) Switzerland $24.500B 0.00
Terumo (TRUMY) Japan $23.332B 26.83
Smith & Nephew SNATS (SNN) United Kingdom $20.451B 0.00
ResMed (RMD) United States $18.758B 35.74
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.664B 51.80
Insulet (PODD) United States $9.336B 553.21
Canopy Growth (CGC) Canada $7.103B 0.00
Perrigo (PRGO) Ireland $7.075B 13.03
Hill-Rom Holdings (HRC) United States $6.550B 19.53
Haemonetics (HAE) United States $6.367B 48.05
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.645B 0.00
Neogen (NEOG) United States $3.284B 54.96
NuVasive (NUVA) United States $3.263B 26.01
ICU Medical (ICUI) United States $3.151B 20.44
Quidel (QDEL) United States $2.356B 23.39
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.303B 0.00
Agios Pharmaceuticals (AGIO) United States $1.869B 0.00
National Vision Holdings (EYE) United States $1.827B 39.44
Aphria (APHA) $1.164B 0.00
VAREX IMAGING (VREX) United States $1.064B 24.53
AtriCure (ATRC) United States $0.978B 0.00
Phibro Animal Health (PAHC) United States $0.849B 13.81
Eagle Pharmaceuticals (EGRX) United States $0.823B 20.97
Omeros (OMER) United States $0.745B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
PetIQ (PETQ) United States $0.722B 17.07
Lantheus Holdings (LNTH) United States $0.721B 18.96
Cerus (CERS) United States $0.623B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.89
Surmodics (SRDX) United States $0.569B 108.08
MacroGenics (MGNX) United States $0.553B 0.00
Quanterix (QTRX) United States $0.529B 0.00
TG Therapeutics (TGTX) United States $0.491B 0.00
OraSure Technologies (OSUR) United States $0.461B 21.34
Owens & Minor (OMI) United States $0.410B 12.28
Meridian Bioscience (VIVO) United States $0.377B 11.76
Zynex (ZYXI) United States $0.362B 38.41
Utah Medical Products (UTMD) United States $0.349B 25.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.312B 0.00
BioLife Solutions (BLFS) United States $0.304B 93.44
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.167B 0.00
Rockwell Medical (RMTI) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.137B 0.00
Female Health (VERU) United States $0.134B 0.00
Fonar (FONR) United States $0.127B 8.93
Chimerix (CMRX) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.084B 19.84
Nephros (NEPH) United States $0.068B 0.00
MTech Acquisition (KERN) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00